Self-reported effects of classic psychedelics on stuttering

Stuttering is a neurodevelopmental disorder marked by intermittent disruptions in speech production and by accessory behaviours such as eye blinking and head jerking. Beyond speech motor symptoms, affective and cognitive reactions—particularly anxiety, fear, shame, anticipatory worry and repetitive negative thinking—play a central role in the lived experience of stuttering and often undermine the durability of gains achieved in behavioural speech therapy. Earlier research establishes that while many children recover, about 20–25% continue to stutter into adulthood, leaving approximately 1% of adults affected and in need of more effective, durable interventions that address both speech and the broader psychosocial consequences of stuttering. This study set out to explore whether classic psychedelics reported in naturalistic use might influence stuttering and related emotional, cognitive and social domains. Gold and colleagues used publicly available posts on Reddit to characterise self‑reported positive, negative and neutral effects of classic psychedelics (psilocybin, LSD, DMT) on people who identify as stutterers, with the aim of informing whether formal clinical trials of psychedelic‑assisted interventions for stuttering would be warranted. The authors framed effects using a five-domain schema (Behaviour, Emotion, Cognition, Beliefs, Social Connection) derived from prior work on psychedelic effects.

The researchers conducted a qualitative content analysis of publicly available Reddit posts. Keyword searches combined terms for stuttering or speech with names of psychedelic drugs (including psilocybin, mushrooms, LSD, DMT; MDMA was used as a search term but posts exclusively about MDMA were excluded). Data comprised posts in English that described first‑hand experiences of classic psychedelics' effects on stuttering; duplicate or third‑hand accounts and posts focused only on non‑classic compounds were removed. Included posts were published between 2012 and 2022. Because the material was public and anonymous, the study was exempt from institutional review board approval; the investigators did not obtain participant demographics. Analysis followed Reflexive Thematic Analysis using a combined inductive–deductive approach. Gold and colleagues first familiarised themselves with the corpus, extracted meaningful units (distinct utterances relevant to psychedelics and stuttering) and excluded unrelated text. Two authors independently coded all meaningful units using the constant comparative method, iteratively refining code labels; two additional authors independently coded a subset for investigator triangulation and the team resolved discrepancies through discussion. In total, 250 meaningful units were identified and assigned codes. After inductive coding, the team applied a deductive framework drawn from van Elk and Yaden to group codes into five subthemes—Behaviour, Emotion (altered and affective states), Cognition, Beliefs, and Social Connection—and to assign overarching valence categories (positive, negative, neutral) to codes and to whole posts. Posts were also rated holistically as positive, negative, neutral or mixed depending on the overall emphasis of the content. The extraction process and coding procedure are reported in the paper; the extracted text does not clearly report whether software assisted coding or the interrater agreement statistics beyond the described consensus process.

The final dataset comprised 114 distinct Reddit posts from unique users, totalling 709 sentences and 250 meaningful units. Across those units the team assigned 77 unique codes and 275 total code instances (units could receive more than one code). Codes were grouped by valence: 216 codes (78.5% of the code sample) were judged positively valenced, 28 codes (10.2%) negatively valenced, and 31 codes (11.3%) neutral. At the participant (post) level, 71.9% of the 114 individuals reported an overall positive experience, 11.4% an overall negative experience, 12.3% a neutral experience, and 4.4% a mixed experience. Positive effects were distributed across five subthemes. Positive behavioural changes were reported by 58.8% of individuals (67/114) with 83 positive behavioural codes; the most common single report was reduced stuttering (54 individuals, 47.4%), with 27 reporting reductions only during the acute psychedelic experience, 17 reporting reductions that persisted beyond the acute effects, and 10 not specifying duration. Additional positive behavioural reports included improved speech (5 individuals), self‑described cures (2 individuals), reduced speaking effort, reduced avoidance, increased speech control (5 individuals), and improved speech flow (7 individuals). Select participant language illustrated the effect, for example some reporting being "the most fluent that [they've] ever been." Positive emotional effects were observed in 41.2% of individuals (47/114) and accounted for 81 codes; these included reductions in anxiety (12 individuals), stress (3), depression (1), increased confidence (7), reduced negative emotional reactions (5) and improved overall wellbeing (10). Positive cognitive effects were present in 18.4% of posts (21/114; 31 codes) and encompassed increased introspection, clarity, reduced self‑consciousness, fewer intrusive thoughts about speech, enhanced cognitive flexibility and other changes in attention or cognitive control. Positive effects on beliefs were reported by 12.3% (14/114; 16 codes), most commonly increased acceptance of one’s identity as a person who stutters (7 individuals) and greater self‑understanding (5). Positive social effects were uncommon (4.4% of individuals; five codes) but included reduced social anxiety and ease of completing conversations. Negative effects were less frequent but notable. Thirteen participants (11.4%) reported increased stuttering or speech difficulty, recorded within negatively valenced behavioural codes contributed by 17 participants overall; four of these increases were described as acute during the psychedelic state and three instances involved carry‑over effects lasting hours or into the morning after. Other negative reports included increased concern or worry about stuttering (3 individuals), cognitive problems such as reduced focus or impaired language formulation (6 individuals), and social difficulty (one individual). The authors report that no participants described persistent long‑term negative effects. Neutral reports included 16 individuals (14.0%) who said psychedelics had no effect on stuttering and 14 individuals (12.3%) who stated psychedelics did not "cure" their stuttering. The dataset also included 45 miscellaneous codes capturing contextual factors: for example, 10 individuals reported microdosing and six emphasised that effects varied by type of psychedelic; some noted reduced effectiveness with repeated use and uncertainty about causation.

Gold and colleagues interpret these findings as preliminary evidence that classic psychedelics, as used in naturalistic contexts, are associated more often with reported improvements than with harms for people who self‑identify as stutterers. The majority of posts described benefits spanning behavioural, emotional, cognitive, belief and social domains, with nearly 50% of participants reporting reductions in stuttering and about 60% reporting positive behavioural change. The authors propose several mechanisms that might underlie these reported benefits: psychedelics may reduce the involvement of top‑down cognitive control processes that can interfere with automatized motor speech, and they may promote psychological states—reduced anxiety, lowered self‑focus, increased acceptance and openness—that make it easier to use speech strategies in real‑world social situations. The investigators emphasise that the majority of negative reports were acute and transient, occurring during the psychedelic experience, and that no long‑term negative side‑effects were described in the sample. Nonetheless, they acknowledge uncertainty about why some individuals experienced worsened speech or tension, noting that individual vulnerability factors (for example, a family or personal history of psychosis or bipolar disorder) and the immediate social and physical context of use (set and setting) are likely important moderators. The authors further point out limitations tied to the data source: posts were anonymous, demographics and clinical histories were not systematically available, and use occurred in uncontrolled naturalistic environments. These constraints limit causal inference and generalisability. On the basis of their analysis, the authors recommend pursuing controlled clinical research using established psychedelic‑assisted psychotherapy models, which include preparatory and integrative therapy and supervised dosing in a therapeutic setting. They suggest that therapist expertise, careful attention to set and setting, and possibly group therapy formats—already a known beneficial modality in stuttering treatment—could be incorporated into future trials. The investigators frame their results as hypothesis‑generating and call for safety and feasibility studies to evaluate psychedelic‑assisted interventions for stuttering in clinical contexts.

People who stutter lack FDA‑approved pharmacotherapies and continue to need treatments that address both speech disruptions and associated psychological distress. Based on this qualitative analysis of Reddit reports, Gold and colleagues conclude that classic psychedelics are commonly reported to produce positive effects on stuttering and wellbeing, and they argue that these preliminary observations warrant formal clinical trials testing psychedelics as adjuncts to traditional stuttering therapies.